×

[;5-Carboxamido or 5-fluoro];-[;2′,3′-unsaturated or 3′-modified];-pyrimidine nucleosides

  • US 6,391,859 B1
  • Filed: 10/02/2000
  • Issued: 05/21/2002
  • Est. Priority Date: 01/27/1995
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating a host infected with human immunodeficiency virus comprising administering an effective amount of a physiologically acceptable ester of β

  • -D-2′

    ,3′

    -dideoxy-2′

    ,3′

    -didehydro-5-fluorocytidine (D4FC) or a pharmaceutically acceptable salt thereof.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×